Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Axial Mobility Exercises in Parkinson Disease

This study has been completed.
Sponsor:
Information provided by:
Office of Rare Diseases (ORD)
ClinicalTrials.gov Identifier:
NCT00004760
First received: February 24, 2000
Last updated: June 23, 2005
Last verified: April 1998

February 24, 2000
June 23, 2005
May 1995
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00004760 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Study of Axial Mobility Exercises in Parkinson Disease
Not Provided

OBJECTIVES:

I. Compare the benefit of exercise versus usual care (no exercise) on impairments and functional limitations in patients with Parkinson disease.

PROTOCOL OUTLINE: This is a randomized study. Patients assigned to the Axial Mobility Exercise Program participate 3 times a week for 10 weeks. The program consists of individualized exercises specifically directed toward restoration of axial mobility in the context of functional tasks.

Patients assigned to the control group receive standard care (no exercise).

Interventional
Not Provided
Primary Purpose: Educational/Counseling/Training
Parkinson Disease
Behavioral: Exercise
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
80
December 1997
Not Provided

PROTOCOL ENTRY CRITERIA:

--Disease Characteristics-- Stage 2 or 3 Parkinson disease (Hoehn/Yahr scale) Able to ambulate independently Able to function independently in home Moderate rigidity No moderate or severe tremor --Prior/Concurrent Therapy-- Concurrent stable pharmacologic regimen required --Patient Characteristics-- Cardiovascular: No unstable angina Other: No psychiatric or medical contraindication to exercise, e.g., dementia, hip fracture; no other neurologic disorder, e.g., stroke, multiple sclerosis; resides within 30 miles of Duke University

Both
50 Years to 90 Years
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00004760
199/11694, DUMC-722955R2
Not Provided
Not Provided
Duke University
Not Provided
Study Chair: Margaret Schenkman Duke University
Office of Rare Diseases (ORD)
April 1998

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP